Actively Recruiting
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
Led by Chinese University of Hong Kong · Updated on 2024-08-29
260
Participants Needed
2
Research Sites
293 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Since much is unknown about factors that lead to progression of the pre-neoplastic lesions and cancer. In addition, there is ongoing debate on the optimal surveillance intervals and techniques. To solve these important clinical questions, the establishment of a registry for a longitudinal study is planned.
CONDITIONS
Official Title
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age or older
- Written informed consent obtained
- Diagnosed with current or past Helicobacter pylori infection
- Histologically confirmed atrophic gastritis, intestinal metaplasia, dysplasia, or post-treatment gastric cancer
You will not qualify if you...
- Co-morbid illness that prohibits endoscopic surveillance
- Declines participation in study questionnaire, biobanking of specimens, or regular review per study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
2
S.H. Ho Centre for Digestive Health, Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
A
Andrew Ming Yeung HO
CONTACT
T
Thomas Yuen Tung LAM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here